Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Assets (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Return on Assets for 5 consecutive years, with 0.55% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets rose 47.0% year-over-year to 0.55%; the TTM value through Mar 2026 reached 0.55%, up 47.0%, while the annual FY2025 figure was 0.69%, 15.0% up from the prior year.
  • Return on Assets hit 0.55% in Q1 2026 for Phathom Pharmaceuticals, up from 0.89% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.55% in Q1 2026 and bottomed at 1.26% in Q1 2023.
  • Average Return on Assets over 5 years is 0.91%, with a median of 0.89% recorded in 2023.
  • Year-over-year, Return on Assets surged 62bps in 2024 and then crashed -39bps in 2025.
  • Phathom Pharmaceuticals' Return on Assets stood at 1.08% in 2022, then skyrocketed by 43bps to 0.62% in 2023, then plummeted by -41bps to 0.87% in 2024, then fell by -1bps to 0.89% in 2025, then soared by 37bps to 0.55% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.55%, 0.89%, and 1.12% for Q1 2026, Q4 2025, and Q3 2025 respectively.